Matthias Durst

Jena, TH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89 publications

Heterogeneous Distribution of Human Papillomavirus (HPV) Integration Sites in Cervical Precancers Compromises the Diagnostic Accuracy of Integrant-Specific PCR.

Heterogeneous Distribution of Human Papillomavirus (HPV) Integration Sites in Cervical Precancers Compromises the Diagnostic Accuracy of Integrant-Specific PCR.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: May 06, 2025

Accuracy of GynTect® Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study.

Accuracy of GynTect® Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study.

Journal: Cancers

Published: July 22, 2024

Evaluation of CIN2/3 Lesion Regression in GynTect® DNA Methylation-Marker-Negative Patients in a Longitudinal Study.

Evaluation of CIN2/3 Lesion Regression in GynTect® DNA Methylation-Marker-Negative Patients in a Longitudinal Study.

Journal: Cancers

Published: July 07, 2023

Association of two genomic variants with HPV type-specific risk of cervical cancer.

Association of two genomic variants with HPV type-specific risk of cervical cancer.

Journal: Tumour virus research

Published: May 12, 2023

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.

Journal: American journal of human genetics

Published: July 13, 2022

Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with O,S Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues.

Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with O,S Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues.

Journal: International journal of molecular sciences

Published: March 22, 2022

Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

Journal: European journal of human genetics : EJHG

Published: March 22, 2022

Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.

Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.

Journal: International journal of molecular sciences

Published: March 22, 2022

Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer.

Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer.

Journal: Human molecular genetics

Published: July 28, 2021

Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance.

Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance.

Journal: Cancers

Published: May 07, 2021

Association of genomic variants at PAX8 and PBX2 with cervical cancer risk.

Association of genomic variants at PAX8 and PBX2 with cervical cancer risk.

Journal: International journal of cancer

Published: January 29, 2021

Evidence for disseminated tumor cells in lymphatic vessels afferent to sentinel lymph nodes in patients diagnosed with cervical cancer.

Evidence for disseminated tumor cells in lymphatic vessels afferent to sentinel lymph nodes in patients diagnosed with cervical cancer.

Journal: Cancer reports (Hoboken, N.J.)

Published: January 20, 2021

Showing 1-12 of 89

Last Updated: 09/26/2026